Regrow Biosciences Private Limited

Regrow Biosciences Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH1989PTC054162 Incorporated 06 November 1989 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company healthcare MSME · Small
Data last updated
Revenue · FY 2025
₹14.52 Cr
▼ 1% YoY
Net loss · FY 2025
₹2.68 Cr
Net margin -18.5%
EBITDA · FY 2025
-₹49.3 Lakh
EBITDA margin -3.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.62 Cr
Issued & subscribed
Open charges
₹5.55 Cr
Satisfied ₹17.24 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
95
Provident fund records

About Regrow Biosciences Private Limited

Data last updated:

Regrow Biosciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 06 November 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1989PTC054162. Its GSTIN is 27AADCS4917N1ZW (Maharashtra). The company holds 5 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.62 Cr. It was formerly known as Regenerative Medical Services Private Limited and Satyan Interchem P Ltd. It is led by directors including Yash Venilal Sanghavi (Managing Director) and Satyen Yeshwant Sanghavi.

Its last annual general meeting (AGM) was held on 30 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.52 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹2.68 Cr (net margin -18.5%) and EBITDA of -₹49.3 Lakh (EBITDA margin -3.4%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.

The company has about 95 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Babycell and Regrow. As per MCA filings, the company has open charges of ₹5.55 Cr and satisfied charges of ₹17.24 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending. The company has 14 deals on record (10 funding rounds, 4 secondary share transfers), with disclosed funding of ₹20.43 Cr; the latest was in July 2021.

Regrow Biosciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0012185). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website regrow.in.

Company details

CIN U24100MH1989PTC054162
Registration Number 054162
Incorporation Date 06 November 1989
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0012185

Name history

Regrow Biosciences has undergone 4 name changes throughout its history. The current legal name is Regrow Biosciences Private Limited.

Company NameStatus
Regrow Biosciences Private LimitedCurrent
Regenerative Medical Services Private LimitedPrevious
Satyan Interchem P LtdPrevious
Regrow Therapeutics Private LimitedPrevious
Regenerative Medical Services LimitedPrevious

CIN history

Regrow Biosciences has one previous CIN (Corporate Identification Number): U24100MH1989PLC054162. The current CIN is U24100MH1989PTC054162, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100MH1989PTC054162Current
U24100MH1989PLC054162Previous

Recognitions & Rankings of Regrow Biosciences

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-18-0012185

Contact details

Regrow Biosciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is regrow.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    A 301 A Wing Polaris Cts 604/A Off Marol Maroshi Road, Nr. Mangalya Complex Andheri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Healthcare, Preventive Health Services, Medical Consumables & Supplies

To see the full contact details of Regrow Biosciences Private Limited, buy the company report.

Comprehensive company report
Regrow Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Regrow Biosciences operates two associated brands: Babycell and Regrow. Each brand links to its own profile.

BrandDescriptionWebsite
Biocell offers stem cell banking from umbilical cord blood for medical treatments.babycell.in
Regrow Biosciences is engaged in regenerative cell therapy solutions.regrow.in

Business activity

The main business activity of Regrow Biosciences is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc. and other hospital and medical care activities. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ2Medical and dental practice, Nursing, pathology, blood bank services, etc.
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Regrow Biosciences Private Limited, buy the company report.

Financials of Regrow Biosciences Private Limited

FY 2025 filings available

Regrow Biosciences Private Limited reported revenue of ₹14.52 Cr (down 1% YoY) for FY 2025.

Revenue · FY 2025
₹14.52 Cr ▼ 1%
Net loss · FY 2025
₹2.68 Cr margin -18.5%
EBITDA · FY 2025
-₹49.3 Lakh margin -3.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 8%
5 years · compounded
▲ 18%

Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 1% fall in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹49.3 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.68 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-3.4%
Net Profit Margin-18.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Regrow Biosciences Private Limited, buy the company report.

Board of directors of Regrow Biosciences Private Limited

Regrow Biosciences has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Satyen Yeshwant SanghaviDirector02 Sep 200818 Years 1 MonthsCurrent
Jill Ashish BhanushaliDirector14 Jun 20179 Years 4 MonthsCurrent
Yash Venilal SanghaviManaging Director06 Nov 198936 Years 11 MonthsCurrent
Gargi Satyen SanghaviDirector16 Dec 201312 Years 10 MonthsCurrent
Bhavna Yash SanghaviDirector06 Nov 198936 Years 11 MonthsCurrent

Auditor

Regrow Biosciences Private Limited is audited by PHD & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PHD & ASSOCIATESFY 2023120229

Shareholding

The shareholding of Regrow Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Regrow Biosciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5.55 Cr
Satisfied charges
₹17.24 Cr
Breakdown by lending institutions
Others₹4.22 Cr
Canara Bank₹1.26 Cr
Kotak Mahindra Prime Limited₹0.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Nov 2025101179004Others₹25.44 LakhOpen
28 Sep 2023100810147Others₹3.97 CrOpen
25 Aug 201510604250Kotak Mahindra Prime Limited₹6.93 LakhOpen
03 Aug 201510593180Canara Bank₹1.26 CrOpen
10 Feb 2021100427726Others₹3.23 CrSatisfied

To see the full charge records of Regrow Biosciences Private Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Regrow Biosciences Private Limited has 14 deals on record (10 funding rounds, 4 secondary share transfers), with disclosed funding of ₹20.43 Cr; the latest was in July 2021.

Total deals
14
Funding rounds
10
Secondary share transfers
4
Disclosed funding
₹20.43 Cr

Deals on record (5 of 14)

WhenDealAmountParties
Jan 2018Funding round₹7.99 CrInvestors: Richmond Asia Investment Limited, Satyan Pharmaceuticals Private Limited
Dec 2016Funding round₹87.2 LakhInvestors: Satyan Pharmaceuticals Private Limited , 2 individuals
Nov 2015Secondary share transferUndisclosedBuyer: an individual
Seller: Satyan Finance and Investments Limited
Sep 2015Secondary share transferUndisclosedBuyer: Satyan Pharmaceuticals Private Limited
Seller: Richmond Asia Investment Limited
Dec 2014Funding round₹1.96 CrInvestors: Satyan Pharmaceuticals Private Limited , Acsus International (S) Private Limited

To see the full deal history of Regrow Biosciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Regrow Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Regrow Biosciences Private Limited has a workforce of 95 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
95
Active EPFO establishments
1
Employee growth
-33.57%

GST

Regrow Biosciences has 5 GST registrations: 1 active and 4 cancelled or inactive.

Total GSTINs
5
Active
1
Cancelled / inactive
4
GSTINStateStatusRegistered on
27AADCS4917N1ZWMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Regrow Biosciences Private Limited, buy the company report.

Recent activity

Regrow Biosciences Private Limited has 16 board changes on record since 1989: 5 appointments and 11 cessations. The latest: Vinayak Virupaksh Kedage ceased to be Director on 01 Dec 2022.

Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 101179004 was registered on 06 Nov 2025.
AGM
Regrow Biosciences Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 3.97 Cr registered on 28 Sep 2023 with Charge ID 100810147 was modified on 30 May 2025.
Filing
Regrow Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 10 Feb 2021 via Charge ID 100427726 with Others was fully satisfied on 20 Dec 2023.
Charges
A charge registered on 27 Aug 2009 via Charge ID 10177275 with Canara Bank was fully satisfied on 20 Dec 2023.
Charges
A charge registered on 27 Aug 2009 via Charge ID 10177270 with Canara Bank was fully satisfied on 20 Dec 2023.
Charges
A charge with Others amounted to Rs. 3.97 Cr with Charge ID 100810147 was registered on 28 Sep 2023.
Ceased
Vinayak Virupaksh Kedage ceased to be Director.
Ceased
Charul Balaram Bhanji ceased to be Director.
Ceased
Subhrojyoti Choudhury ceased to be Director.
Ceased
Dipakbhai Lallubhai Sheth ceased to be Director.

23 earlier events are in the company report.

Frequently asked questions

Regrow Biosciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 06 November 1989 (37+ years old) and is registered under CIN U24100MH1989PTC054162.

Regrow Biosciences has 5 current directors:

The latest financial statements of Regrow Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 October 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Regrow Biosciences is 27AADCS4917N1ZW, registered in Maharashtra. The company has 5 GST registrations in all, of which 1 is active and 4 are cancelled or inactive.

The CIN (Corporate Identification Number) of Regrow Biosciences is U24100MH1989PTC054162. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Regrow Biosciences has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Regrow Biosciences was incorporated on 06 November 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.

Regrow Biosciences has 14 deals on record (10 funding rounds, 4 secondary share transfers), with disclosed funding of ₹20.43 Cr; the latest was in July 2021.

Vinayak Virupaksh Kedage ceased to be Director on 01 Dec 2022. Charul Balaram Bhanji ceased to be Director on 10 Oct 2022. Subhrojyoti Choudhury ceased to be Director on 10 Oct 2022. Regrow Biosciences has 16 board changes on record in total.

Yes, Regrow Biosciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0012185).